Detalhe da pesquisa
1.
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
JAMA
; 331(5): 408-416, 2024 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319331
2.
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.
MMWR Morb Mortal Wkly Rep
; 71(11): 422-428, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298453
3.
Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years - PROTECT Cohort, Four States, July 2021-May 2022.
MMWR Morb Mortal Wkly Rep
; 71(35): 1109-1114, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048723
4.
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study.
Vaccine
; 42(7): 1512-1520, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307743
5.
Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study.
JMIR Res Protoc
; 11(7): e37929, 2022 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35635842